Description

De-nol tablets 120 mg. №56

Ingredients

De-nol tablets contain 120 mg of bismuth subcitrate. Other inactive ingredients include microcrystalline cellulose, povidone, colloidal anhydrous silica, magnesium stearate, talc, and hypromellose.

Dosage

The recommended dosage of De-nol tablets is one tablet (120 mg) four times a day. It is essential to follow the prescribed dosage and duration of treatment as directed by a healthcare professional.

Indications

De-nol tablets are indicated for the treatment of peptic ulcers, gastritis, and Helicobacter pylori infection. They work by forming a protective barrier over the ulcer site, promoting healing and reducing symptoms.

Contraindications

Do not use De-nol tablets if you are allergic to bismuth subcitrate or any other ingredients in the tablets. It is important to inform your healthcare provider about any existing medical conditions or medications before starting De-nol therapy.

Directions

Swallow the tablets whole with a glass of water. It is recommended to take De-nol tablets at least one hour before or two hours after meals. Avoid taking any antacids within the same timeframe.

Scientific Evidence

De-nol tablets have been extensively studied for their efficacy in treating peptic ulcers and Helicobacter pylori infection. Research published in the International Journal of Antimicrobial Agents has shown that bismuth subcitrate, the active ingredient in De-nol, exhibits potent antimicrobial activity against Helicobacter pylori, contributing to the eradication of the bacteria and ulcer healing.

Additional Information

In addition to its antimicrobial properties, De-nol tablets also possess cytoprotective effects on the gastric mucosa, helping to prevent further damage and promoting ulcer healing. Clinical trials have demonstrated the safety and efficacy of De-nol in both short-term and long-term treatment regimens, making it a valuable option for patients with peptic ulcers and gastritis.

Overall, De-nol tablets 120 mg. №56 offer a comprehensive approach to the management of peptic ulcers and related conditions, backed by scientific evidence and clinical experience.